| 2026-03-31 |
详情>>
业绩披露：
2025年年报每股收益1.83美元,归母净利润19.33亿美元,同比去年增长-5.09%
|
| 2026-02-20 |
详情>>
股本变动：
变动后总股本50591.20万股
|
| 2026-02-18 |
财报披露：
美东时间 2026-02-18 盘后发布财报
|
| 2025-10-30 |
详情>>
业绩披露：
2025年三季报(累计)每股收益1.39美元,归母净利润14.84亿美元,同比去年增长-2.39%
|
| 2025-08-01 |
详情>>
业绩披露：
2025年中报每股收益0.97美元,归母净利润10.38亿美元,同比去年增长-3.16%
|
| 2025-05-01 |
详情>>
业绩披露：
2025年一季报每股收益0.47美元,归母净利润5.07亿美元,同比去年增长-31.22%
|
| 2025-04-01 |
详情>>
业绩披露：
2024年年报每股收益1.81美元,归母净利润20.36亿美元,同比去年增长-48.02%
|
| 2025-04-01 |
详情>>
业绩披露：
2022年年报每股收益2.16美元,归母净利润25.53亿美元,同比去年增长132.08%
|
| 2024-11-07 |
详情>>
业绩披露：
2024年三季报(累计)每股收益1.34美元,归母净利润15.20亿美元,同比去年增长-45.49%
|
| 2024-08-02 |
详情>>
业绩披露：
2024年中报每股收益0.93美元,归母净利润10.72亿美元,同比去年增长-52.38%
|
| 2024-04-29 |
详情>>
业绩披露：
2024年一季报每股收益0.64美元,归母净利润7.37亿美元,同比去年增长-34.7%
|
| 2024-03-28 |
详情>>
业绩披露：
2023年年报每股收益3.32美元,归母净利润39.18亿美元,同比去年增长53.45%
|
| 2024-03-27 |
股东大会：
将于2024-04-30召开股东大会
会议内容 ▼▲
- 1.Consideration of (i) the Company’s 2023 annual report containing the consolidated management report and related management certifications on the Company’s consolidated financial statements as of and for the year ended 31st December 2023, and on the annual accounts as at 31st December 2023, and the external auditors’ reports on such consolidated financial statements and annual accounts and; (ii) the Company’s 2023 annual sustainability report containing the non-financial statement.
2.Approval of the Company’s consolidated financial statements as of and for the year ended 31st December 2023.
3.Approval of the Company’s annual accounts as at 31st December 2023.
4.Allocation of results and approval of dividend payment for the year ended 31st December 2023.
5.Discharge of the members of the Board of Directors for the exercise of their mandate throughout the year ended 31st December 2023.
6.Election of the members of the Board of Directors.
7.Approval of the compensation payable to the members of the Board of Directors for the year ending 31st December 2024.
8.Approval of the Company’s compensation report for the year ended 31st December 2023.
9.Approval of the Company’s compensation policy applicable to the members of the Board of Directors and the Chief Executive Officer.
10.Approval of the external auditors’ fees for the fiscal year ending 31st December 2024.
11.Authorization to the Board of Directors to cause the distribution of all shareholder communications, including its shareholder meeting and proxy materials and annual reports to shareholders, by such electronic means as is permitted by any applicable laws or regulations.
12.Approval of the cancellation of 17,779,302 ordinary shares held in treasury by the Company acquired by the Company throughout the first tranche of its share buyback program, consequential reduction of the issued share capital of the Company by an amount of US$17,779,302 so as to bring it from its current amount of US$1,180,536,830 to US$1,162,757,528 represented by 1,162,757,528 ordinary shares with a nominal value of US$1.00 each; and consequential amendment of the first paragraph of article 5 “Share Capital” of the Company’s articles of association to reflect the resolutions on this item of the agenda.
|
| 2023-04-05 |
股东大会：
将于2023-05-03召开股东大会
会议内容 ▼▲
- 1.Consideration of (i) the Company’s 2022 annual report containing the consolidated management report and related management certifications on the Company’s consolidated financial statements as of and for the year ended 31st December 2022, and on the annual accounts as at 31st December 2022, and the external auditors’ reports on such consolidated financial statements and annual accounts and; (ii) the Company’s 2022 annual sustainability report containing the non-financial statement.
2.Approval of the Company’s consolidated financial statements as of and for the year ended 31st December 2022.
3.Approval of the Company’s annual accounts as at 31st December 2022.
4.Allocation of results and approval of dividend payment for the year ended 31st December 2022.
5.Discharge of the members of the Board of Directors for the exercise of their mandate throughout the year ended 31st December 2022.
6.Election of the members of the Board of Directors.
7.Approval of the compensation payable to the members of the Board of Directors for the year ending 31st December 2023.
8.Approval of the Company’s compensation report for the year ended 31st December 2022.
9.Appointment of the external auditors for the fiscal year ending 31st December 2023, and approval of their fees.
10.Appointment of the external auditors for the fiscal year ending 31st December 2024.
11.Authorization to the Board of Directors to cause the distribution of all shareholder communications, including its shareholder meeting and proxy materials and annual reports to shareholders, by such electronic means as is permitted by any applicable laws or regulations.
|
| 2022-04-05 |
股东大会：
将于2022-05-03召开股东大会
会议内容 ▼▲
- 1.Consideration of (i) the Company’s 2021 annual report containing the consolidated management report and related management certifications on the Company’s consolidated financial statements as of and for the year ended 31st December 2021, and on the annual accounts as at 31st December 2021, and the external auditors’ reports on such consolidated financial statements and annual accounts; and (ii) the Company’s 2021 annual sustainability report containing the non-financial statement.
2.Approval of the Company’s consolidated financial statements as of and for the year ended 31st December 2021.
3.Approval of the Company’s annual accounts as at 31st December 2021.
4.Allocation of results and approval of dividend payment for the year ended 31st December 2021.
5.Discharge of the members of the Board of Directors for the exercise of their mandate throughout the year ended 31st December 2021.
6.Election of the members of the Board of Directors.
7.Approval of the compensation payable to the members of the Board of Directors for the year ending 31st December 2022.
8.Approval of the Company's compensation report for the year ended 31st December 2021.
9.Appointment of the external auditors for the fiscal year ending 31st December 2022, and approval of their fees.
10.Authorization to the Board of Directors to cause the distribution of all shareholder communications, including its shareholder meeting and proxy materials and annual reports to shareholders, by such electronic means as is permitted by any applicable laws or regulations.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-01 |
股东大会：
将于2021-05-03召开股东大会
会议内容 ▼▲
- 1.Consideration of the consolidated management report and related management certifications on the Company’s consolidated financial statements as of and for the year ended 31st December 2020, and on the annual accounts as at 31st December 2020, and of the external auditors’ reports on such consolidated financial statements and annual accounts.
2.Approval of the Company’s consolidated financial statements as of and for the year ended 31st December 2020.
3.Approval of the Company’s annual accounts as at 31st December 2020.
4.Allocation of results and approval of dividend payment for the year ended 31st December 2020.
5.Discharge of the members of the Board of Directors for the exercise of their mandate throughout the year ended 31st December 2020.
6.Election of the members of the Board of Directors.
7.Approval of the compensation payable to the members of the Board of Directors for the year ending 31st December 2021.
8.Approval of the Company’s compensation report for the year ended 31st December 2020.
9.Appointment of the external auditors for the fiscal year ending 31st December 2021, and approval of their fees.
10.Authorization to the Board of Directors to cause the distribution of all shareholder communications, including its shareholder meeting and proxy materials and annual reports to shareholders, by such electronic means as is permitted by any applicable laws or regulations.
|
| 2020-05-04 |
股东大会：
将于2020-06-02召开股东大会
会议内容 ▼▲
- Agenda for the Annual General Meeting of Shareholders
1.Consideration of the consolidated management report and related management certifications on the Company’s consolidated financial statements as of and for the year ended 31st December 2019, and on the annual accounts as at 31st December 2019, and of the external auditors’ reports on such consolidated financial statements and annual accounts.
2.Approval of the Company’s consolidated financial statements as of and for the year ended 31st December 2019.
3.Approval of the Company’s annual accounts as at 31st December 2019.
4.Allocation of results and approval of dividend for the year ended 31st December 2019.
5.Discharge of the members of the Board of Directors for the exercise of their mandate throughout the year ended 31st December 2019.
6.Election of the members of the Board of Directors.
7.Approval of the Company’s compensation policy applicable to the members of the Board of Directors and the Chief Executive Officer.
8.Approval of the Company’s compensation report for the year ended 31st December 2019.
9.Appointment of the external auditors for the fiscal year ending 31st December 2020, and approval of their fees.
10.Authorization to the Company, or any subsidiary, to from time to time purchase, acquire or receive securities of the Company, in accordance with Article 49-2 of the Luxembourg law of 10 August 1915 and with applicable laws and regulations.
11.Authorization to the Board of Directors to cause the distribution of all shareholder communications, including its shareholder meeting and proxy materials and annual reports to shareholders, by such electronic means as is permitted by any applicable laws or regulations.
Agenda for the Extraordinary General Meeting of Shareholders
12.Decision on the renewal of the authorized share capital of the Company and related authorizations and waivers by:
a.the renewal of the validity period of the Company’s authorized share capital for a period starting on the date of the Extraordinary General Meeting of Shareholders and ending on the fifth anniversary of the date of the publication in the Recueil électronique des sociétés et associations (RESA) of the deed recording the minutes of such meeting;
b.the renewal of the authorization to the board of directors, or any delegate(s) duly appointed by the board of directors, for a period starting on the date of the Extraordinary General Meeting of Shareholders and ending on the fifth anniversary of the date of the publication in the RESA of the deed recording the minutes of such meeting, from time to time to issue shares within the limits of the authorized share capital against contributions in cash, contributions in kind or by way of incorporation of available reserves at such times and on such terms and conditions, including the issue price, as the board of directors or its delegate (s) may in its or their discretion resolve;
c.the renewal of the authorization to the board of directors, for a period starting on the date of the Extraordinary General Meeting of Shareholders and ending on the fifth anniversary of the date of the publication in the RESA of the deed recording the minutes of such meeting, to waive, suppress or limit any pre-emptive subscription rights of shareholders provided for by law to the extent it deems such waiver, suppression or limitation advisable for any issue or issues of shares within the authorized share capital; waiver of any pre-emptive subscription rights provided for by law and related procedures;
d.the decision that any issuance of shares for cash within the limits of the authorized share capital shall be subject by provision of the Company’s articles of association to the pre-emptive subscription rights of the then existing shareholders, except in the following cases (in which cases no pre-emptive rights shall apply):
i.any issuance of shares (including, without limitation, the direct issuance of shares or upon the exercise of options, rights convertible into shares, or similar instruments convertible or exchangeable into shares) against a contribution other than in cash;
ii.any issuance of shares (including by way of free shares or at discount), up to an amount of 1.5% of the issued share capital of the Company, to directors, officers, agents, employees of the Company, its direct or indirect subsidiaries, or its affiliates (collectively, the “Beneficiaries”), including without limitation the direct issuance of shares or upon the exercise of options, rights convertible into shares, or similar instruments convertible or exchangeable into shares issued for the purpose of compensation or incentive of the Beneficiaries or in relation thereto (which the Board of Directors shall be authorized to issue upon such terms and conditions as it deems fit).
e.the acknowledgement and approval of the report of the Board of Directors in relation with the authorized share capital and the proposed authorizations to the Board of Directors with respect to any issuance of shares within the authorized share capital while suppressing any pre-emptive subscription rights of existing shareholders under law and related waiver;
f.the amendment of article 5 “Share Capital” of the Company’s articles of association to reflect the resolutions on this item of the agenda.
|
| 2019-10-30 |
除权日：
美东时间 2019-11-18 每股派息0.26美元
|
| 2019-04-08 |
股东大会：
将于2019-05-06召开股东大会
会议内容 ▼▲
- 1.Consideration of the consolidated management report and related management certifications on the Company’s consolidated financial statements as of and for the year ended 31 December 2018, and on the annual accounts as at 31 December 2018, and of the external auditors’ reports on such consolidated financial statements and annual accounts.
2.Approval of the Company’s consolidated financial statements as of and for the year ended 31 December 2018.
3.Approval of the Company’s annual accounts as at 31 December 2018.
4.Allocation of results and approval of dividend payment for the year ended 31 December 2018.
5.Discharge of the members of the Board of Directors for the exercise of their mandate throughout the year ended 31 December 2018.
6.Election of the members of the Board of Directors.
7.Authorization of the compensation of the members of the Board of Directors.
8.Appointment of the external auditors for the fiscal year ending 31 December 2019, and approval of their fees.
9.Authorization to the Board of Directors to cause the distribution of all shareholder communications, including its shareholder meeting and proxy materials and annual reports to shareholders, by such electronic means as is permitted by any applicable laws or regulations.
|
| 2018-11-28 |
复牌提示：
2018-11-27 15:32:40 停牌，复牌日期 2018-11-28 07:21:25
|
| 2018-10-31 |
除权日：
美东时间 2018-11-19 每股派息0.26美元
|
| 2018-04-02 |
股东大会：
将于2018-05-02召开股东大会
会议内容 ▼▲
- 1.Consideration of the consolidated management report and related management certifications on the Company’s consolidated financial statements as of and for the year ended December 31, 2017, and on the annual accounts as at December 31, 2017, and of the independent auditors’ reports on such consolidated financial statements and annual accounts.
2.Approval of the Company’s consolidated financial statements as of and for the year ended December 31, 2017.
3.Approval of the Company’s annual accounts as at December 31, 2017.
4.Allocation of results and approval of dividend payment for the year ended December 31, 2017.
5.Discharge of the members of the Board of Directors for the exercise of their mandate throughout the year ended December 31, 2017.
6.Election of the members of the Board of Directors.
7.Authorization of the compensation of the members of the Board of Directors.
8.Appointment of the independent auditors for the fiscal year ending December 31, 2018, and approval of their fees.
9.Authorization to the Board of Directors to cause the distribution of all shareholder communications, including its shareholder meeting and proxy materials and annual reports to shareholders, by such electronic means as is permitted by any applicable laws or regulations.
|
| 2017-11-01 |
除权日：
美东时间 2017-11-20 每股派息0.26美元
|
| 2017-05-06 |
除权日：
美东时间 2017-05-19 每股派息0.56美元
|
| 2017-04-05 |
股东大会：
将于2017-05-03召开股东大会
会议内容 ▼▲
- 1.Consideration of the consolidated management report and related management certifications on the Company's consolidated financial statements as of and for the year ended December 31, 2016, and on the annual accounts as at December 31, 2016, and of the independent auditors' reports on such consolidated financial statements and annual accounts.
2.Approval of the Company's consolidated financial statements as of and for the year ended December 31, 2016.
3.Approval of the Company's annual accounts as at December 31, 2016.
4.Allocation of results and approval of dividend payment for the year ended December 31, 2016.
5.Discharge of the members of the Board of Directors for the exercise of their mandate throughout the year ended December 31, 2016.
6.Election of the members of the Board of Directors.
7.Authorization of the compensation of the members of the Board of Directors.
8.Appointment of the independent auditors for the fiscal year ending December 31, 2017, and approval of their fees.
9.Authorization to the Board of Directors to cause the distribution of all shareholder communications, including its shareholder meeting and proxy materials and annual reports to shareholders, by such electronic means as is permitted by any applicable laws or regulations.
|
| 2016-11-03 |
除权日：
美东时间 2016-11-21 每股派息0.26美元
|
| 2016-05-09 |
除权日：
美东时间 2016-05-23 每股派息0.60美元
|
| 2016-02-25 |
股东大会：
将于2016-05-04召开股东大会
会议内容 ▼▲
- 1.Consideration of the restated consolidated management report and related management certifications on the Company's restated consolidated financial statements as of and for the year ended December 31, 2014, and on the annual accounts as at December 31, 2014, and of the independent auditors' reports on such restated consolidated financial statements and annual accounts.
2.Approval of the Company's restated consolidated financial statements as of and for the year ended December 31, 2014.
3.Consideration of the consolidated management report and related management certifications on the Company's consolidated financial statements as of and for the year ended December 31, 2015, and on the annual accounts as at December 31, 2015, and of the independent auditors' reports on such consolidated financial statements and annual accounts.
4.Approval of the Company's consolidated financial statements as of and for the year ended December 31, 2015.
5.Approval of the Company's annual accounts as at December 31, 2015.
6.Allocation of results and approval of dividend payment for the year ended December 31, 2015.
7.Discharge of the members of the Board of Directors for the exercise of their mandate throughout the year ended December 31, 2015.
8.Election of the members of the Board of Directors.
9.Authorization of the compensation of the members of the Board of Directors.
10.Appointment of the independent auditors for the fiscal year ending December 31, 2016, and approval of their fees.
11.Authorization to the Board of Directors to cause the distribution of all shareholder communications, including its shareholder meeting and proxy materials and annual reports to shareholders, by such electronic means as is permitted by any applicable laws or regulations.
|
| 2015-11-06 |
除权日：
美东时间 2015-11-23 每股派息0.30美元
|
| 2015-05-11 |
除权日：
美东时间 2015-05-18 每股派息0.60美元
|
| 2015-04-02 |
股东大会：
将于2015-05-06召开股东大会
会议内容 ▼▲
- Agenda for the Annual General Meeting of Shareholders
1. Consideration of the consolidated management report and related management certifications on the Company’s consolidated financial statements as of and for the year ended December 31, 2014, and on the annual accounts as at December 31, 2014, and of the independent auditors’ reports on such consolidated financial statements and annual accounts.
2. Approval of the Company’s consolidated financial statements as of and for the year ended December 31, 2014.
3. Approval of the Company’s annual accounts as at December 31, 2014.
4. Allocation of results and approval of dividend payment for the year ended December 31, 2014.
5. Discharge of members of the Board of Directors for the exercise of their mandate throughout the year ended December 31, 2014.
6. Election of members of the Board of Directors.
7. Authorization of the compensation of members of the Board of Directors.
8. Appointment of the independent auditors for the fiscal year ending December 31, 2015, and approval of their fees.
9. Authorization to the Company, or any subsidiary, to from time to time purchase, acquire or receive securities of the Company, in accordance with Article 49-2 of the Luxembourg law of 10 August 1915 and with applicable laws and regulations.
10. Authorization to the Board of Directors to cause the distribution of all shareholder communications, including its shareholder meeting and proxy materials and annual reports to shareholders, by such electronic means as is permitted by any applicable laws or regulations.
Agenda for the Extraordinary General Meeting of Shareholders
1. Decision on the renewal of the authorized share capital of the Company and related authorizations and waivers by:
a. the renewal of the validity period of the Company’s authorized share capital for a period starting on the date of the Extraordinary General Meeting of Shareholders and ending on the fifth anniversary of the date of the publication in the Mémorial of the deed recording the minutes of such meeting;
b. the renewal of the authorization to the Board of Directors, or any delegate(s) duly appointed by the Board of Directors, for a period starting on the date of the Extraordinary General Meeting of Shareholders and ending on the fifth anniversary of the date of the publication in the Mémorial of the deed recording the minutes of such meeting, from time to time to issue shares within the limits of the authorized share capital against contributions in cash, contributions in kind or by way of incorporation of available reserves at such times and on such terms and conditions, including the issue price, as the Board of Directors or its delegate(s) may in its or their discretion resolve;
c. the renewal of the authorization to the Board of Directors, for a period starting on the date of the Extraordinary General Meeting of Shareholders and ending on the fifth anniversary of the date of the publication in the Mémorial of the deed recording the minutes of such meeting, to waive, suppress or limit any pre-emptive subscription rights of shareholders provided for by law to the extent it deems such waiver, suppression or limitation advisable for any issue or issues of shares within the authorized share capital; waiver of any pre-emptive subscription rights provided for by law and related procedures;
d. the decision that any issuance of shares for cash within the limits of the authorized share capital shall be subject by provision of the Company’s articles of association to the pre-emptive subscription rights of the then existing shareholders, except in the following cases (in which cases no pre-emptive rights shall apply):
i. any issuance of shares (including, without limitation, the direct issuance of shares or upon the exercise of options, rights convertible into shares, or similar instruments convertible or exchangeable into shares) against a contribution other than in cash;
ii. any issuance of shares (including by way of free shares or at discount), up to an amount of 1.5% of the issued share capital of the Company, to directors, officers, agents, employees of the Company, its direct or indirect subsidiaries, or its affiliates (collectively, the “Beneficiaries”), including without limitation the direct issuance of shares or upon the exercise of options, rights convertible into shares, or similar instruments convertible or exchangeable into shares issued for the purpose of compensation or incentive of the Beneficiaries or in relation thereto (which the Board of Directors shall be authorized to issue upon such terms and conditions as it deems fit).
e. the acknowledgement and approval of the report of the Board of Directors in relation with the authorized share capital and the proposed authorizations to the Board of Directors with respect to any issuance of shares within the authorized share capital while suppressing any pre-emptive subscription rights of existing shareholders under law and related waiver;
f. the amendment of article 5 “Share Capital” of the Company’s articles of association to reflect the resolutions on this item of the agenda.
|
| 2014-11-05 |
除权日：
美东时间 2014-11-24 每股派息0.30美元
|
| 2014-05-07 |
除权日：
美东时间 2014-05-19 每股派息0.60美元
|
| 2014-04-02 |
股东大会：
将于2014-05-07召开股东大会
会议内容 ▼▲
- 1. Consideration of the consolidated management report and related management certifications on the Company’s consolidated financial statements as of and for the year ended 31 December 2013, and on the annual accounts as at 31 December 2013, and of the independent auditors’ reports on such consolidated financial statements and annual accounts.
2. Approval of the Company’s consolidated financial statements as of and for the year ended 31 December 2013.
3. Approval of the Company’s annual accounts as at 31 December 2013.
4. Allocation of results and approval of dividend payment for the year ended 31 December 2013.
5. Discharge of the members of the Board of Directors for the exercise of their mandate during the year ended 31 December 2013.
6. Election of members of the Board of Directors.
7. Compensation of members of the Board of Directors.
8. Appointment of the independent auditors for the fiscal year ending 31 December 2014, and approval of their fees.
9. Authorization to the Board of Directors to cause the distribution of all shareholder communications, including its shareholder meeting and proxy materials and annual reports to shareholders, by such electronic means as is permitted by any applicable laws or regulations.
|
| 2013-11-07 |
除权日：
美东时间 2013-11-18 每股派息0.26美元
|
| 2013-05-03 |
除权日：
美东时间 2013-05-20 每股派息0.60美元
|
| 2012-11-07 |
除权日：
美东时间 2012-11-20 每股派息0.26美元
|
| 2012-05-09 |
除权日：
美东时间 2012-05-21 每股派息0.50美元
|
| 2011-11-11 |
除权日：
美东时间 2011-11-21 每股派息0.26美元
|
| 2011-06-07 |
除权日：
美东时间 2011-06-20 每股派息0.42美元
|
| 2010-11-10 |
除权日：
美东时间 2010-11-22 每股派息0.26美元
|
| 2010-06-04 |
除权日：
美东时间 2010-06-21 每股派息0.42美元
|